Llwytho...
PPAR Agonists for the Prevention and Treatment of Lung Cancer
Lung cancer is the most common and most fatal of all malignancies worldwide. Furthermore, with more than half of all lung cancer patients presenting with distant metastases at the time of initial diagnosis, the overall prognosis for the disease is poor. There is thus a desperate need for new prevent...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | PPAR Res |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Hindawi Publishing Corporation
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5337885/ https://ncbi.nlm.nih.gov/pubmed/28316613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8252796 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|